Juan Carlos Lacal. Show Affiliations »
Abstract
Entities: Species
Mesh: See more » Antibodies, Monoclonal/therapeutic useAntineoplastic Agents/therapeutic useDrug DesignDrug Resistance, NeoplasmHumansMultigene FamilyNeoplasms/drug therapyPatientsProtein Kinase Inhibitors/therapeutic useProtein-Tyrosine Kinases/antagonists & inhibitorsProtein-Tyrosine Kinases/geneticsProtein-Tyrosine Kinases/physiologyTreatment Outcome
Substances: See more » Antibodies, MonoclonalAntineoplastic AgentsProtein Kinase InhibitorsProtein-Tyrosine Kinases
Year: 2006 PMID: 16648096 DOI: 10.1007/BF02664931
Source DB: PubMed Journal: Clin Transl Oncol ISSN: 1699-048X Impact factor: 3.405